Kv1.3 Target Global Collaboration Map: Who’s at the Table and Who Is Your Best Negotiating Partner? 2025-07-31
Explore the global collaboration landscape for Kv1.3-targeting drugs in 2024, highlighting key clinical players, regional licensing preferences, and strategic partner selection. Learn how to identify ideal license-out opportunities and leverage Unibest's international BD expertise to maximize your drug pipeline's value.
Read More